Perspective Therapeutics, Inc. CATX
0.75 USD -0.03 (-3.85%)
Regular-session close
0.75 0.00 -0.50%
After hours · Nov 20, 6:45 PM ET
0.7407 Day range 0.79
0.7538 52-week range 5.65
- YTD
- -72.59%
- 1 year
- -64.44%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|
| 884.00K | 1.45M | 1.43M | 0 | 10.05M | |
| 884.00K | 1.45M | 1.43M | 0 | 5.12M | |
| -113.56M | -90.89M | -40.94M | -6.42M | -3.45M | |
| -103.12M | -79.28M | -46.51M | -7.27M | -3.39M | |
| -1.40 | -1.23 | -1.74 | -0.50 | -0.30 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|
| 30.63M | 61.58M | 9.42M | 56.07M | 64.01M | |
| 266.97M | 341.10M | 97.89M | 64.44M | 70.42M | |
| 59.94M | 50.43M | 22.71M | 3.16M | 3.01M | |
| 3.25M | 4.06M | 2.55M | 524.00K | 776.00K | |
| 207.03M | 290.67M | 75.18M | 61.28M | 67.41M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|
| -82.48M | -18.29M | -36.91M | -7.71M | -2.84M | |
| 41.23M | -218.93M | 24.37M | -284.00K | -410.00K | |
| 10.30M | 289.38M | 785.00K | 56.00K | 64.68M | |
| -12.75M | -54.08M | -1.07M | -266.00K | -380.00K | |
| -30.95M | 52.16M | -11.76M | -7.94M | 61.44M |
